TENTECH Inc. (CEO Dong-ok Han, hereinafter referred to as 'TENTECH'), a medical device company specializing in aesthetics, announced on the 8th that its monopolar radiofrequency (RF) device, ‘10THERMA,’ has surpassed 1,800 units in global cumulative sales.

In the highly competitive skin aesthetics medical device market, 10THERMA achieved this global milestone of 1,800 units by recording sales of 1,000 units in the domestic South Korean market and 800 units in overseas markets.

10THERMA utilizes a 6.78MHz radiofrequency band with a maximum output of 400W to deliver deep dermal heat. Through this mechanism, it is widely utilized in procedures aimed at improving skin elasticity.

The device is equipped with a 5.0cm² Face Tip, providing a wider treatment area and enabling faster procedures for the same number of shots. It is designed to deliver energy broadly and deeply, utilizing the Smart Temperature Cooling (S.T.C) system and Impedance Matching technology to support energy delivery and a treatment environment customized to each individual's skin characteristics.

Furthermore, based on clinical research papers, 10THERMA's results regarding collagen increase rates compared to other companies' RF equipment have been verified, and research outcomes on the improvement of collagen fiber density and arrangement within the dermis have been reported. These results were presented at an exclusive seminar attended by global aesthetic and plastic surgery experts during the 'IMCAS World Congress 2026', where 10THERMA's clinical data and application cases were shared. Based on these proven results, the device has obtained medical device certifications from South Korea (MFDS), the United States (FDA), the European Union (CE MDR), Australia (TGA), Brazil (ANVISA), and India (CDSCO).

While Asian countries such as Taiwan, Thailand, Singapore, Malaysia, and Indonesia have previously accounted for a significant portion of TENTECH's export volume, the company plans to target the Americas and Latin American markets, including the United States and Brazil, moving forward. Backed by the European CE MDR certification, TENTECH aims to expand its market share focusing on key global markets, including advanced European markets, Russia (which recently granted regulatory approval), and the high-potential Indian market.

Dong-ok Han, CEO of TENTECH, stated, "Reaching 1,800 units in cumulative sales is a meaningful milestone achieved based on 10THERMA's technological capability and clinical research findings in the global medical aesthetics market." He added, "Backed by verified clinical data and multiple SCI-level papers, we will strengthen our marketing activities through our global distributor network."

He further noted, "While Asian markets like Taiwan, Thailand, and Singapore have driven our exports so far, we anticipate generating significant results in the US, Latin American markets like Brazil, the European market based on CE MDR certification, as well as Russia and India. We will continue our global market expansion to hit our next milestones of 2,000 units and eventually 3,000 units in cumulative sales."